DMAA
Stimulant, Research-chemical, Habit-forming, Nootropic
Also known as methylhexanamine, this sympathetomimetic drug was developed as a nasal decongestant by Eli Lilly in the 1940s. It has been used as a weight loss aid and missold as a dietary supplement and component of some energy drinks. Carries a risk of heart attack, stroke and other life-threatening cardiovascular issues.
Rapid onset.
Chart shows bounded mass ranges in mg. See the table for all doses.
Threshold
Light
Common
Strong
Oral
5-10mg
10-20mg
20-50mg
50-100mg
Duration
Oral
2 to 4